Contact Us
Cholestatic Pruritus Global Market Report 2025
Global Cholestatic Pruritus Market Report 2025
Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Cholestatic Pruritus Global Market Report 2025

By Disease Type (Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis of Pregnancy (ICP), Other Disease Types), By Treatment Type (Medications, Phototherapy, Other Treatment Types), By Route Of Administration (Oral, Topical, Injectable), By End-User (Hospitals, Clinics, Ambulatory Care Centers, Homecare) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cholestatic Pruritus Market Overview

• Cholestatic Pruritus market size has reached to $19.2 billion in 2024

• Expected to grow to $24.78 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%

• Growth Driver: Increasing Prevalence Of Liver Diseases Driving Growth In The Market

• Market Trend: Improving Patient Compliance With Once-Daily Oral Treatments

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cholestatic Pruritus Market?

Cholestatic pruritus refers to severe itching caused by the buildup of bile acids in the skin, typically resulting from liver diseases that impair bile flow. This condition can significantly affect a patient's quality of life and often requires targeted treatment to manage the discomfort and address the underlying liver dysfunction.

The main disease types of cholestatic pruritus are Primary Biliary Cholangitis (PBC), primary sclerosing cholangitis (PSC), intrahepatic cholestasis of pregnancy (ICP), and other disease types. Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease that causes progressive destruction of the bile ducts, leading to bile buildup, liver damage, and potential cirrhosis. Treatment options for cholestatic pruritus include medications, phototherapy, and other treatment types, with routes of administration such as oral, topical, and injectable. The key end-users for these treatments are hospitals, clinics, ambulatory care centers, and home care.

Cholestatic Pruritus Market Size and growth rate 2025 to 2029: Graph

What Is The Cholestatic Pruritus Market Size 2025 And Growth Rate?

The cholestatic pruritus market size has grown strongly in recent years. It will grow from $19.2 billion in 2024 to $20.22 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to the rising prevalence of skin disorders, growing investments in research and development, demand for effective treatments, rising awareness of the disease, and favorable regulatory environments.

What Is The Cholestatic Pruritus Market Growth Forecast?

The cholestatic pruritus market size is expected to see strong growth in the next few years. It will grow to $24.78 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to the increasing elderly population, increasing prevalence of atopic dermatitis and urticaria, increase in the geriatric population, increase in chronic kidney diseases, and growing prevalence of conditions associated with pruritus. Major trends in the forecast period include the introduction of new treatment options, partnerships with major businesses for cholestasis pruritus research, innovation in treatment modalities, expansion of healthcare facilities, and technological innovation.

The forecast of 5.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. hepatology care by inflating prices of ileal bile acid transporter inhibitors and opioid antagonist medications developed in the UK and Belgium, resulting in prolonged suffering and higher liver clinic expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Cholestatic Pruritus Market Segmented?

1) By Disease Type: Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis of Pregnancy (ICP), Other Disease Types

2) By Treatment Type: Medications, Phototherapy, Other Treatment Types

3) By Route Of Administration: Oral, Topical, Injectable

4) By End-User: Hospitals, Clinics, Ambulatory Care Centers, Homecare

Subsegments:

1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC, Advanced PBC, PBC With Cirrhosis, PBC With Liver Failure

2) By Primary Sclerosing Cholangitis (PSC): Classic PSC, PSC With Ulcerative Colitis, PSC With Bile Duct Strictures

3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP, Severe ICP, ICP With Preterm Birth Risk

4) By Other Disease Types: Alcoholic Cholestasis, Drug-Induced Cholestasis, Viral Hepatitis-Induced Cholestasis, Genetic Cholestasis Disorders

What Is Driving The Cholestatic Pruritus Market? Increasing Prevalence Of Liver Diseases Driving Growth In The Market

The increasing prevalence of liver diseases is expected to propel the growth of the cholestatic pruritus market going forward. Liver diseases are a broad range of conditions that affect liver function, including infections, autoimmune disorders, genetic diseases, and damage from toxins, leading to inflammation, scarring, or liver failure. The growing prevalence of liver diseases is fueled by increasing obesity, diabetes, alcohol use, viral hepatitis infections, and exposure to toxins and environmental factors. Cholestatic pruritus helps in the identification and management of liver diseases by serving as a key symptom that indicates impaired bile flow, often prompting further investigation and treatment of underlying hepatic conditions. For instance, in July 2023, according to the Office for Health Improvement and Disparities, a UK-based government body focused on addressing health inequalities, hospital admissions for liver disease in England increased by 22% in the year ending 2022, rising from 67,458 to 82,290. Therefore, the increasing prevalence of liver diseases will drive the growth of the cholestatic pruritus industry.

Who Are The Major Players In The Global Cholestatic Pruritus Market?

Major companies operating in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., Aquatic Remedies Private Limited.

What Are The Key Trends Of The Global Cholestatic Pruritus Market? Improving Patient Compliance With Once-Daily Oral Treatments

Major companies operating in the cholestatic pruritus market are focusing on developing innovative solutions, such as oral solutions to manage symptoms more effectively, improve patient compliance, and provide targeted relief by addressing the underlying causes of bile salt accumulation and inflammation. An oral solution for the treatment of cholestatic pruritus is a liquid formulation of medication designed to reduce bile acid accumulation and alleviate severe itching in patients with cholestasis. For instance, in March 2024, Mirum Pharmaceuticals Inc., a US-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for LIVMARLI (maralixibat) oral solution for treating cholestatic pruritus in patients aged five and older with progressive familial intrahepatic cholestasis (PFIC). This once-daily, orally administered ileal bile acid transporter inhibitor holds a breakthrough therapy designation for PFIC type 2. LIVMARLI is poised to make a significant impact on patients with cholestatic pruritus linked to PFIC, offering a much-needed treatment option for those with the rarest subtypes.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Cholestatic Pruritus Market? Travere Therapeutics Partners With Mirum Pharmaceuticals To Expand Rare Liver Disease Portfolio

In September 2023, Travere Therapeutics Inc., a US-based biopharmaceutical company, partnered with Mirum Pharmaceuticals Inc. With this partnership, Travere aims to focus on its core therapeutic areas while enabling Mirum Pharmaceuticals to expand its portfolio and continue the development and commercialization of bile acid therapies for rare liver diseases. Mirum Pharmaceuticals Inc. is a US-based company focused on developing and commercializing therapies for rare liver diseases, including those that lead to cholestatic pruritus.

What Is The Regional Outlook For The Global Cholestatic Pruritus Market?

North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cholestatic Pruritus  Market?

The cholestatic pruritus market consists of revenues earned by entities by providing services such as diagnosis and screening services, medical consultations and treatment management, patient support programs, and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The cholestatic pruritus market also includes sales of ursodeoxycholic acid, topical corticosteroids, and opioid antagonists. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cholestatic Pruritus  Industry?

The cholestatic pruritus market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cholestatic pruritus industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Cholestatic Pruritus Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $20.22 billion
Revenue Forecast In 2034 $24.78 billion
Growth Rate CAGR of 5.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The cholestatic pruritus market covered in this report is segmented –
1) By Disease Type: Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis of Pregnancy (ICP), Other Disease Types
2) By Treatment Type: Medications, Phototherapy, Other Treatment Types
3) By Route Of Administration: Oral, Topical, Injectable
4) By End-User: Hospitals, Clinics, Ambulatory Care Centers, Homecare Subsegments:
1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC, Advanced PBC, PBC With Cirrhosis, PBC With Liver Failure
2) By Primary Sclerosing Cholangitis (PSC): Classic PSC, PSC With Ulcerative Colitis, PSC With Bile Duct Strictures
3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP, Severe ICP, ICP With Preterm Birth Risk
4) By Other Disease Types: Alcoholic Cholestasis, Drug-Induced Cholestasis, Viral Hepatitis-Induced Cholestasis, Genetic Cholestasis Disorders
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., Aquatic Remedies Private Limited.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Cholestatic Pruritus Market Characteristics

3. Cholestatic Pruritus Market Trends And Strategies

4. Cholestatic Pruritus Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cholestatic Pruritus Growth Analysis And Strategic Analysis Framework

5.1. Global Cholestatic Pruritus PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cholestatic Pruritus Market Growth Rate Analysis

5.4. Global Cholestatic Pruritus Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cholestatic Pruritus Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cholestatic Pruritus Total Addressable Market (TAM)

6. Cholestatic Pruritus Market Segmentation

6.1. Global Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Primary Biliary Cholangitis (PBC)

Primary Sclerosing Cholangitis (PSC)

Intrahepatic Cholestasis of Pregnancy (ICP)

Other Disease Types

6.2. Global Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medications

Phototherapy

Other Treatment Types

6.3. Global Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Topical

Injectable

6.4. Global Cholestatic Pruritus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Ambulatory Care Centers

Homecare

6.5. Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Biliary Cholangitis (PBC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Early-Stage PBC

Advanced PBC

PBC With Cirrhosis

PBC With Liver Failure

6.6. Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Sclerosing Cholangitis (PSC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Classic PSC

PSC With Ulcerative Colitis

PSC With Bile Duct Strictures

6.7. Global Cholestatic Pruritus Market, Sub-Segmentation Of Intrahepatic Cholestasis of Pregnancy (ICP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mild ICP

Severe ICP

ICP With Preterm Birth Risk

6.8. Global Cholestatic Pruritus Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alcoholic Cholestasis

Drug-Induced Cholestasis

Viral Hepatitis-Induced Cholestasis

Genetic Cholestasis Disorders

7. Cholestatic Pruritus Market Regional And Country Analysis

7.1. Global Cholestatic Pruritus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cholestatic Pruritus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cholestatic Pruritus Market

8.1. Asia-Pacific Cholestatic Pruritus Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cholestatic Pruritus Market

9.1. China Cholestatic Pruritus Market Overview

9.2. China Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cholestatic Pruritus Market

10.1. India Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cholestatic Pruritus Market

11.1. Japan Cholestatic Pruritus Market Overview

11.2. Japan Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cholestatic Pruritus Market

12.1. Australia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cholestatic Pruritus Market

13.1. Indonesia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cholestatic Pruritus Market

14.1. South Korea Cholestatic Pruritus Market Overview

14.2. South Korea Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cholestatic Pruritus Market

15.1. Western Europe Cholestatic Pruritus Market Overview

15.2. Western Europe Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cholestatic Pruritus Market

16.1. UK Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cholestatic Pruritus Market

17.1. Germany Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cholestatic Pruritus Market

18.1. France Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cholestatic Pruritus Market

19.1. Italy Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cholestatic Pruritus Market

20.1. Spain Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cholestatic Pruritus Market

21.1. Eastern Europe Cholestatic Pruritus Market Overview

21.2. Eastern Europe Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cholestatic Pruritus Market

22.1. Russia Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cholestatic Pruritus Market

23.1. North America Cholestatic Pruritus Market Overview

23.2. North America Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cholestatic Pruritus Market

24.1. USA Cholestatic Pruritus Market Overview

24.2. USA Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cholestatic Pruritus Market

25.1. Canada Cholestatic Pruritus Market Overview

25.2. Canada Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cholestatic Pruritus Market

26.1. South America Cholestatic Pruritus Market Overview

26.2. South America Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cholestatic Pruritus Market

27.1. Brazil Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cholestatic Pruritus Market

28.1. Middle East Cholestatic Pruritus Market Overview

28.2. Middle East Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cholestatic Pruritus Market

29.1. Africa Cholestatic Pruritus Market Overview

29.2. Africa Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cholestatic Pruritus Market Competitive Landscape And Company Profiles

30.1. Cholestatic Pruritus Market Competitive Landscape

30.2. Cholestatic Pruritus Market Company Profiles

30.2.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cholestatic Pruritus Market Other Major And Innovative Companies

31.1. Incyte Corporation

31.2. Ipsen Pharma

31.3. Vanda Pharmaceuticals Inc.

31.4. Medison Pharma Ltd.

31.5. Mirum Pharmaceuticals Inc.

31.6. Albireo Pharma Inc.

31.7. Dipharma Francis S.r.l.

31.8. Cara Therapeutics Inc.

31.9. CANbridge Pharmaceuticals Inc.

31.10. Escient Pharmaceuticals Inc.

31.11. Tharimmune Inc.

31.12. Vifor Fresenius Medical Care Renal Pharma

31.13. CymaBay Therapeutics Inc.

31.14. ICE Pharma Inc.

31.15. Aquatic Remedies Private Limited

32. Global Cholestatic Pruritus Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cholestatic Pruritus Market

34. Recent Developments In The Cholestatic Pruritus Market

35. Cholestatic Pruritus Market High Potential Countries, Segments and Strategies

35.1 Cholestatic Pruritus Market In 2029 - Countries Offering Most New Opportunities

35.2 Cholestatic Pruritus Market In 2029 - Segments Offering Most New Opportunities

35.3 Cholestatic Pruritus Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cholestatic Pruritus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Biliary Cholangitis (PBC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Sclerosing Cholangitis (PSC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cholestatic Pruritus Market, Sub-Segmentation Of Intrahepatic Cholestasis of Pregnancy (ICP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cholestatic Pruritus Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cholestatic Pruritus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Cholestatic Pruritus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: GlaxoSmithKline plc Financial Performance
  • Table 80: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 81: Merck KGaA Financial Performance
  • Table 82: Regeneron Pharmaceuticals Inc. Financial Performance
  • Table 83: Bausch Health Companies Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cholestatic Pruritus Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Biliary Cholangitis (PBC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cholestatic Pruritus Market, Sub-Segmentation Of Primary Sclerosing Cholangitis (PSC), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cholestatic Pruritus Market, Sub-Segmentation Of Intrahepatic Cholestasis of Pregnancy (ICP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cholestatic Pruritus Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cholestatic Pruritus Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Cholestatic Pruritus Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Cholestatic Pruritus Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Cholestatic Pruritus Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Cholestatic Pruritus Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: GlaxoSmithKline plc Financial Performance
  • Figure 80: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 81: Merck KGaA Financial Performance
  • Figure 82: Regeneron Pharmaceuticals Inc. Financial Performance
  • Figure 83: Bausch Health Companies Inc. Financial Performance

Frequently Asked Questions

Cholestatic pruritus refers to severe itching caused by the buildup of bile acids in the skin, typically resulting from liver diseases that impair bile flow. This condition can significantly affect a patient's quality of life and often requires targeted treatment to manage the discomfort and address the underlying liver dysfunction. For further insights on this market, request a sample here

The market major growth driver - Increasing Prevalence Of Liver Diseases Driving Growth In The Market. For further insights on this market, request a sample here

The cholestatic pruritus market size has grown strongly in recent years. It will grow from $19.2 billion in 2024 to $20.22 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to the rising prevalence of skin disorders, growing investments in research and development, demand for effective treatments, rising awareness of the disease, and favorable regulatory environments. The cholestatic pruritus market size is expected to see strong growth in the next few years. It will grow to " $24.78 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to the increasing elderly population, increasing prevalence of atopic dermatitis and urticaria, increase in the geriatric population, increase in chronic kidney diseases, and growing prevalence of conditions associated with pruritus. Major trends in the forecast period include the introduction of new treatment options, partnerships with major businesses for cholestasis pruritus research, innovation in treatment modalities, expansion of healthcare facilities, and technological innovation. For further insights on this market, request a sample here

The cholestatic pruritusmarket covered in this report is segmented –
1) By Disease Type: Primary Biliary Cholangitis (PBC); Primary Sclerosing Cholangitis (PSC); Intrahepatic Cholestasis of Pregnancy (ICP); Other Disease Types
2) By Treatment Type: Medications; Phototherapy; Other Treatment Types
3) By Route Of Administration: Oral; Topical; Injectable
4) By End-User: Hospitals; Clinics; Ambulatory Care Centers; Homecare Subsegments:
1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC; Advanced PBC; PBC With Cirrhosis; PBC With Liver Failure
2) By Primary Sclerosing Cholangitis (PSC): Classic PSC; PSC With Ulcerative Colitis; PSC With Bile Duct Strictures
3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP; Severe ICP; ICP With Preterm Birth Risk
4) By Other Disease Types: Alcoholic Cholestasis; Drug-Induced Cholestasis; Viral Hepatitis-Induced Cholestasis; Genetic Cholestasis Disorders For further insights on this market,
request a sample here

North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cholestatic pruritus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., Aquatic Remedies Private Limited. . For further insights on this market, request a sample here.

Major trends in this market include Improving Patient Compliance With Once-Daily Oral Treatments. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon